Clinical trials in primary hepatocellular carcinoma: current status and future directions
Cancer Treat Rev
.
1988 Mar;15(1):1-31.
doi: 10.1016/0305-7372(88)90007-2.
Authors
S R Nerenstone
1
,
D C Ihde
,
M A Friedman
Affiliation
1
Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland 20892.
PMID:
2834053
DOI:
10.1016/0305-7372(88)90007-2
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Hepatocellular / therapy*
Humans
Liver Neoplasms / therapy*
Substances
Antineoplastic Agents